2. Pharmacotherapy of Obsessive-Compulsive Disorder
- Joseph Zohar3,4
Published Online: 12 JUN 2012
DOI: 10.1002/9781119941125.ch2
Copyright © 2012 John Wiley & Sons, Ltd
Book Title
Obsessive-Compulsive Disorder: Current Science and Clinical Practice
Additional Information
How to Cite
Decloedt, E. H. and Stein, D. J. (2012) Pharmacotherapy of Obsessive-Compulsive Disorder, in Obsessive-Compulsive Disorder: Current Science and Clinical Practice (ed J. Zohar), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119941125.ch2
Editor Information
- 3
Psychiatry Department A, Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel
- 4
Tel Aviv University, Tel Aviv, Israel
Publication History
- Published Online: 12 JUN 2012
- Published Print: 13 MAR 2012
ISBN Information
Print ISBN: 9780470711255
Online ISBN: 9781119941125
- Summary
- Chapter
- References
Keywords:
- pharmacotherapy of obsessive-compulsive disorder;
- OCD patients in pharmacological, measurement using scales;
- drug pharmacokinetics in children, differing from adults;
- fluoxetine use in childhood OCD;
- meta-analysis, comparing efficacy of agents in OCD;
- clomipramine, serotonin reuptake inhibitors in OCD;
- switching SSRIs, in treatment-resistant OCD;
- treatment-refractory OCD, clinical issue;
- added cognitive behavioural psychotherapy
Summary
This chapter contains sections titled:
Introduction
Placebo-controlled studies of clomipramine
Placebo-controlled studies of fluvoxamine
Placebo-controlled studies of fluoxetine
Placebo-controlled studies of paroxetine
Placebo-controlled studies of sertraline
Placebo-controlled studies of citalopram/escitalopram
Placebo-controlled studies of venlafaxine
Improving early response in OCD
Special populations: children
Clomipramine
Meta-analyses
Tolerability of clomipramine and serotonin reuptake inhibitors
Optimal dose of treatment
Duration of treatment
Refractory OCD
Future therapeutic options
Conclusion
References